Andreas Fibig to Leave Bayer HealthCare
Andreas Fibig, president of Bayer HealthCare Pharmaceuticals, will leave the company to become CEO of International Flavors & Fragrances on Sept. 1, 2014. Bayer said it would nominate a successor shortly.
Andreas Fibig, president of Bayer HealthCare Pharmaceuticals, will leave the company to become CEO of International Flavors & Fragrances on Sept. 1, 2014. Bayer said it would nominate a successor shortly.

Honeywell will acquire Johnson Matthey's Catalyst Technologies business segment for €2.15 billion in an all-cash transaction.

This interview covers key results of the study ‘Success Factor Supply Chain Management and Logistics in the Chemical Industry 2024’ by Solventure, Aimms and Miebach.

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Oxea is returning to its old name and its roots.

Valerie Diele-Braun resigned from her position as CEO and member of the Executive Board of IMCD at the end of April for personal reasons.